Lack of association between the Hind III RFLP of the osteocalcin (BGP) gene and bone mineral density (BMD) in healthy pre- and postmenopausal Chinese women

Xiao-Yang Mo,Chi-Ke Cao,Fu-Hua Xu,Man-Yuan Liu,Miao-Xin Li,Yue-Juan Qin,Qi Zhou,Yuan-Yuan Zhang,Hong-Wen Deng
DOI: https://doi.org/10.1007/s00774-003-0478-7
2004-01-01
Journal of Bone and Mineral Metabolism
Abstract:In Caucasian populations, the polymorphic restriction endonuclease Hind III marker of the osteocalcin (also known as BGP , for bone Gla protein) gene has recently been reported to be associated with bone mass, a major risk determinant of osteoporosis. In this study, we investigated the relationship between the BGP Hind III polymorphism and bone mineral density (BMD) in 388 premenopausal (31.18 ± 5.92 years) and 169 postmenopausal (58.90 ± 6.27 years) Chinese women. The BMD of spine and hip was measured by dual-energy X-ray absorptiometry (DEXA). All the study subjects were genotyped at the Hind III site of the BGP gene by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) detecting methods. The BGP alleles were designated according to the absence ( H ) or presence ( h ) of the Hind III restriction site. We did not find any significant difference in spine and hip BMD across BGP genotypes in either pre- or postmenopausal women or the combined group. Our result is not consistent with recent reports that the Hind III marker of the BGP gene is associated with osteoporosis. The different findings may reflect inter-population differences in the association (i.e., linkage disequilibrium) of molecular markers with BMD, and indicate the limit of using the Hind III marker of the BGP gene as a genetic marker to discern women susceptible to low BMD and thus osteoporosis in Chinese.
What problem does this paper attempt to address?